FindMyKOL
Clinical trialNCT03750227RecruitingPhase 3Interventional

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

SponsorMayo ClinicEnrollment140Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase III trial studies the side effects and how well stereotactic radiosurgery (SRS) works before or after surgery in patients with tumors that has spread to the brain or that can be removed by surgery. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic in Arizona

    Scottsdale, Arizona, United States

    Sujay A. Vora, M.D.
    Recruiting
  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

    Daniel Trifiletti, M.D.
    Recruiting
  • Nih Clinical Center

    Bethesda, Maryland, United States

    DeeDee K. Smart, M.D., Ph.D.
    Recruiting
  • Mayo Clinic in Rochester

    Rochester, Minnesota, United States

    Elizabeth S. Yan, M.D.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Nov 2018
Primary completion
8 Nov 2030
Completion
8 Nov 2030
Last update posted
19 Aug 2026
Registered enrollment
140
Registry id
NCT03750227

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.